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The ICD-11 Classification of Personality Disorders delineates five trait domain qualifiers
(i.e., negative affectivity, detachment, dissociality, disinhibition, and anankastia), whereas
the DSM-5 Alternative Model of Personality Disorders also delineates a separate domain
of psychoticism. These six combined traits not only characterize individual stylistic
features, but also the severity of their maladaptive expressions. It was, therefore, the aim
of this study to investigate the utility of ICD-11 and DSM-5 trait domains to differentiate
patients with personality disorders (PD) from patients with other mental disorders (non-
PD). The Personality Inventory for DSM-5 Brief Form Plus (PID5BF+M) was administered
to a sample of patients diagnosed with a personality disorder (N = 124, Mage = 42.21,
42.7% females) along with a sample of patients diagnosed with other mental disorders
(N = 335, Mage = 44.83, 46.6% females). Group differences were explored using the
independent sample t test or the Mann–Whitney U test for independent samples, and
discriminant factor analysis was used to maximize group differences for each trait domain
and facet score. The PD group showed significantly higher scores for the total PID5BF+M
composite score, for the trait domains of negative affectivity, antagonism/dissociality,
and disinhibition and for the trait facets of emotional lability, manipulativeness,
deceitfulness, and impulsivity. The trait domains of disinhibition, negative affectivity,
and antagonism/dissociality as well as the trait facets of impulsivity, deceitfulness,
emotional lability, and manipulativeness were the best discriminators between PD and
non-PD patients. The global PID5BF+M composite score was also one of the best
discriminators supporting its potential as a global severity index for detecting personality
dysfunction. Finally, high scores in three or more of the 18 PID5BF+M facets suggested
the possible presence of a PD diagnosis. Despite some limitations, our findings
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suggest that the ICD-11 and DSM-5 traits have the potential to specifically describe
the stylistic features that characterize individuals with PD, including the severity of their
maladaptive expressions.
Keywords: ICD-11 classification of personality disorders, DSM-5 alternative model for personality disorders,
personality disorders, severity, personality traits, PID5BF+M
INTRODUCTION
There is broad consensus within the scientific community as
to the supremacy of dimensional classification models over
categorical models in the diagnosis of personality disorders (PD)
(1, 2). Moreover, a growing body of research suggests that the
global severity of personality dysfunction should be central for
PD diagnosis (3–5) while individual maladaptive expressions are
best described in terms of specific traits (6, 7). A PD classification
system based on severity is expected to simplify the diagnostic
process and is far more beneficial to clinical practice, allowing
for a clear identification of those who are more disturbed and
require a more intensive intervention (e.g., hospitalization vs.
outpatient treatment). However, the stylistic manifestations of
personality dysfunction may reveal specific areas of difficulty and
are, therefore, also important to identify. Style indicates the likely
expression of the pathology and gears the clinician toward the
most appropriate type of intervention (3, 6, 8).
Reflecting this trend, the recently released ICD-11
Classification of Personality Disorders (9) and the DSM-5
Alternative Model of Personality Disorders (AMPD) (10)
consider impairments in self and interpersonal functioning
as the core feature of PD and delineate levels of dysfunction.
As mentioned, personality dysfunction may have different
phenotypic manifestations with implications for treatment and
outcomes. Therefore, both classification systems use pathological
traits to characterize the stylistic expression of personality
dysfunction. In the ICD-11 model, the traits are specifiers of
personality dysfunction (i.e., severe personality dysfunction
is expected to be associated with several pathological traits)
while the DSM-5 model defines constellations of traits that
characterize six personality disorders (e.g., for the diagnosis
of borderline personality disorder, in addition to moderate
or greater personality dysfunction, four or more of seven
pathological traits must be present and at least one must be
impulsivity, risk taking, or hostility) (9, 10). The trait domains
considered in both models are negative affectivity, detachment,
antagonism/dissociality, and disinhibition. The two models
particularly differ in terms of the psychoticism domain, which
is not considered a personality trait domain in the ICD-11,
and in terms of the anankastia domain, whose equivalent in
the DSM-5 (compulsivity) was not retained in the final AMPD
model for reasons of parsimony (9, 10). Additionally, the DSM-5
recognizes facets within each trait domain, and the ICD-11
does not. Both models have made efforts to operationalize these
specific trait features. The Personality Inventory for ICD-11
(11) and the Personality Inventory for DSM-5 (PID5) (12) have
proven to efficiently assess the maladaptive traits of each model,
helping clinicians to easily capture the most salient traits in
each patient.
Considering the similarity of both classification systems,
it would be helpful to clinicians if these two systems were
harmonized (13, 14). In fact, as previously mentioned, the
preliminary versions of the DSM-5 included a compulsivity
domain, akin to anankastia (15). Currently, the DSM-5
addresses compulsivity/anankastia in terms of a low score
in the disinhibition domain (i.e., rigid perfectionism) and
a high score in perseveration (10). However, experts stress
that rigid perfectionism and perseveration do not capture
the complexity of the compulsivity dimension (16, 17), and
research findings support a distinct compulsivity/anankastia
domain (13, 14, 18). In contrast to the DSM-5, the ICD-
11 does not consider psychoticism as a personality feature
as it describes mental functioning (bizarre behavior, unusual
thoughts, and experiences) that characterizes schizophrenic
spectrum disorders. Nonetheless, the DSM-5 psychoticism
domain captures features of schizotypy that are close to normal
functioning (i.e., unconventionality in appearance and thinking),
therefore ranging from atypical normal functioning to more
extreme schizophrenic-like features.
Recently, Kerber et al. (19) developed the Personality
Inventory for the DSM-5—Brief Form Plus (PID5BF+), an
algorithm that assesses the DSM-5 and ICD-11 six trait domains
(negative affectivity, detachment, antagonism/dissociality,
disinhibition, anankastia, and psychoticism) and 17 facets.
In the PID5BF+, the anankastia domain aligns with the
DSM-5 algorithm and consists of the rigid perfectionism and
perseveration facets. To better capture the features of the
ICD-11 domain of anankastia, Bach et al. (14) developed a
modified version of the PID5BF+, the PID5BF+M, in which
the perseveration facet, which contributes to the negative
affectivity domain, was excluded and the orderliness, rigidity,
and perfectionism sub-facets of the original rigid perfectionism
facet were added. These three new anankastia facets are in
keeping with the initial 37-facet version of the DSM-5 trait
model that included the compulsivity domain (15). Apart from
these changes in the composition of the anankastia domain, the
other PID5BF+ domains have remained unchanged. Therefore,
each PID5BF+M domain is composed of three facets, and each
facet is composed of two items. The PID5BF+M was validated
with international PID5 data. Although the ICD-11 classification
system does not describe personality at a facet level, research
with the PID5BF+M (14) reveals that the ICD-11 trait domain
may be adequately characterized by means of DSM-5 trait facets.
According to the ICD-11 approach, global PD severity rather
than specific trait qualifiers are meant to differentiate PD
Frontiers in Psychiatry | www.frontiersin.org 2 April 2021 | Volume 12 | Article 633882
Pires et al. PID5BF+M: Differentiating PP From Non-PP
from non-PD patients. Nevertheless, it is well-established that
severity represents the global quality (“g-factor”) that links
all maladaptive personality features (3, 6, 8, 20). Moreover,
the ICD-11 PD classification states that individuals with more
severe personality disturbance tend to have a greater number of
prominent trait domains (9). This implies higher scores across
the trait domains, thus indicating more complexity, which, in
turn, indicates PD severity. Therefore, the number, complexity,
and severity of maladaptive traits indicate the global severity
of personality dysfunction (3). This is also consistent with
the official PID5 user’s guide, which literally instructs users to
calculate the overall personality dysfunction score (i.e., total and
individual PID5 scores) to track changes in the severity of the
individual’s personality dysfunction over time (10). Moreover,
research supports the understanding that PID-5 traits are
substantially related to measures of functional impairment (21).
The current study sought to investigate the utility of the
PID5BF+M total score along with specific domain and facet
scores in differentiating patients with PDs from other psychiatric
patients. The use of the PID5BF+ as a proxy of severity is
particularly supported in a comparative study by Zimmermann
et al. (22), which found the total PID5BF+ score to align well
with a number of PD severity measures.
MATERIALS AND METHODS
Participants and Procedures
The sample of patients with PD consisted of 124 patients aged
between 18 and 68 years (Mage = 42.21 years, SD = 11.76 years,
57.3% males, 42.7% females), 64.5% of whom had a cluster B
diagnosis (56.6% had borderline personality disorder). In the PD
sample, 56.5% of the patients had comorbid psychopathology.
The most common comorbid disorders included substance-
related and addictive (22.6%), depressive (17.7%), and bipolar
disorders (10.5%).
The sample of patients with other diagnoses (39.1%
depressive, 29.6% substance-related and addictive, and 15.5%
bipolar and related disorders) was composed of 335 patients, aged
18 to 76 years (Mage = 44.83 years, SD = 12.59 years, 53.4%
males, 46.6% females). Individuals with a comorbid PD were
excluded from this sample.
Data collection was carried out within the scope of the
adaptation of the PID5 (12) for Portugal. The study design
was approved by the ethics committees of the affiliated and
host institutions, and the research protocol consisted of a
sociodemographic questionnaire and four personality tests, one
of which was the PID5. At the time of data collection, the
patients were having treatment at mental health units. In each
affiliated mental health institution, a psychiatrist or psychologist
(co-authors of this paper) coordinated the sampling procedures.
Patients were selected according to their DSM-5 diagnosis and
the study’s inclusion and exclusion criteria. The study inclusion
criteria were adults above 18 years undergoing treatment
at mental health units. Diagnoses of intellectual disability,
schizophrenia, and major and mild neurocognitive disorders
were the exclusion criteria. Some of the patients responded
to the research protocol during brief hospitalization periods
(for conditions such as eating or affective disorders). Others
were outpatients, admitted sequentially in the sample whenever
they had a follow-up consultation. Patients were informed
that participation in the study was voluntary, that they could
withdraw their participation at any time, that no identifying
information would be asked, and that the data would be used
exclusively in a scientific study.
Instruments
PID5BF+M: The Modified Version of the PID5BF+ (14). The
PID5BF+ (19) is a 34-item self-report that was developed to
combine DSM-5 and ICD-11 traits within six domains (negative
affectivity, detachment, antagonism/dissociality, disinhibition,
anankastia, and psychoticism). The selection of items from the
original PID5 item pool was carried out by means of ant colony
optimization algorithms [see details in Kerber et al. (19)]. In
the PID5BF+M (14), the anankastia domain was revised, and
the changes in its operationalization were empirically validated
[see details in Bach et al. (14)]. The PID5BF+M comprises 36
items that delineate 18 facets in the six trait domains (three
facets per domain). High scores indicate greater dysfunction in
a specific trait facet or domain (14). Following the procedure of
Zimmermann et al. (22) for the PID5BF+, a total PID5BF+M
score was also computed as a global index of personality
dysfunction. Our PID5BF+M data was derived from complete
PID5 data.
Data Analysis
Analyses were undertaken with IBM SPSS Statistics (v.25, SPSS
Inc., Chicago, IL). Descriptive statistics for the facets, domains,
and total PID5BF+M score were obtained, and the domains’
and total PID5BF+M score reliability was examined through
Cronbach’s alphas in both PD and non-PD samples. To explore
the normality of the scales’ distributions, the following criteria
were used: skewness, kurtosis, Kolmogorov–Smirnov goodness-
of-fit test (N > 30), steam and leaf diagrams, and Q-Q plots.
Group differences were explored using the independent sample
t test whenever the PID5BF+M scales followed a normal
distribution. Effect sizes were tested through Cohen’s d, in which
the effect size was considered small when d ≤ 2.0, medium when
0.20 < d ≤ 0.50, large when 0.50 < d ≤ 1.0, and very large when
d > 1.0. The Mann–Whitney U test for independent samples
was used when the PID5BF+M scales did not follow a normal
distribution. Effect sizes were tested through r= Z/
√
N, N= nPD
+ nnon−PD, in which the effect size was considered small when
0.10≤ r < 0.30, mediumwhen: 0.30≤ r < 0.50, and large when: r
≥ 0.50. Discriminant factor analysis was used to maximize group
differences in each PID5BF+M trait domain and facet. Finally,
the minimum number of facets with high rates [>2 (23)] that
differentiate PD from non-PD diagnosis was examined.
RESULTS
Cronbach’s alphas for the six PID5BF+M domains were
moderate although slightly higher in the non-PD sample. In the
PD sample, the mean Cronbach’s alpha was 0.70, ranging from
0.65 at the lowest level for detachment to 0.76 for psychoticism.
Frontiers in Psychiatry | www.frontiersin.org 3 April 2021 | Volume 12 | Article 633882
Pires et al. PID5BF+M: Differentiating PP From Non-PP
TABLE 1 | PID5BF+M scales’ means (M), standard deviations (SD), t tests (t) and effect sizes (d) in the personality disorder (PD) and non-personality disorder
(non-PD) samples.
PD Non-PD
(N = 124) (N = 335)
M SD M SD t p d
Emotional lability 1.85 0.87 1.65 0.85 2.26 0.012 0.23
Anxiety 1.98 0.87 1.92 0.88 0.74 0.231
Separation insecurity 1.53 0.89 1.38 0.87 1.62 0.054
Withdrawal 1.14 0.83 1.13 0.84 0.15 0.443
Anhedonia 1.30 0.86 1.18 0.83 1.32 0.100
Intimacy avoidance 0.88 0.86 1.02 0.88 −1.56 0.060
Manipulativeness 0.75 0.83 0.58 0.77 2.07 0.020 0.21
Deceitfulness 1.26 0.87 1.06 0.78 2.30 0.011 0.25
Grandiosity 0.88 0.82 0.86 0.81 0.28 0.389
Irresponsibility 0.83 0.80 0.73 0.78 1.21 0.114
Impulsivity 1.69 0.81 1.42 0.80 3.20 0.000 0.34
Distractibility 1.71 0.79 1.60 0.76 1.41 0.079
Unusual beliefs & experiences 1.21 0.87 1.12 0.87 1.01 0.156
Eccentricity 1.15 0.90 1.03 0.84 1.33 0.093
Perceptual dysregulation 0.80 0.86 0.75 0.77 0.64 0.261
Perfectionism 1.50 0.85 1.48 0.85 0.09 0.463
Rigidity 1.91 0.71 1.83 0.75 1.09 0.138
Orderliness 1.05 0.76 1.06 0.83 −0.12 0.455
Negative affectivity 1.79 0.63 1.65 0.60 2.19 0.015 0.23
Detachment 1.11 0.60 1.11 0.64 −0.078 0.469
Antagonism 0.96 0.64 0.83 0.62 2.05 0.021 0.21
Disinhibition 1.41 0.60 1.25 0.58 2.62 0.005 0.26
Psychoticism 1.05 0.69 0.96 0.68 1.28 0.101
Anankastia 1.48 0.59 1.46 0.65 0.435 0.332
Total PID5BF+M 1.30 0.40 1.21 0.43 2.03 0.022 0.21
Small effect: d ≤ 2.0, medium effect: 0.20 < d ≤ 0.50, large effect: 0.50 < d ≤ 1.0, and very large effect: d > 1.0.
Regarding the non-PD sample, the mean Cronbach’s alpha was
0.72, ranging from 0.66 at the lowest level for negative affectivity
to 0.77 for psychoticism. As for the total PID5BF+M score, in
the PD sample the alpha was 0.86, and in the non-PD sample the
alpha was 0.89.
Table 1 presents the descriptive statistics, t tests, and effect
sizes for all the PID5BF+M scales although seven scales
(anxiety, withdrawal, intimacy avoidance, manipulativeness,
unusual beliefs and experiences, eccentricity, and orderliness)
did not lean toward normality. Considering the robustness of
parametric statistics against non-normality variables and for the
sake of clarity in the results’ presentation, the option was taken to
present the t test results, discussing eventual discrepancies with
the Mann–Whitney U results whenever necessary.
The PD group showed significantly higher scores for
the PID5BF+M total score, the trait domains of negative
affectivity, antagonism, and disinhibition, and for the trait
facets of emotional lability, manipulativeness, deceitfulness and
impulsivity. A small effect size was found for manipulativeness
with the Mann–Whitney U (Z = −2.189, p = 0.015, r = 0.10),
whereas effect sizes tested through Cohen’s d were medium for
the total score and all the trait facets and domains.
Discriminant factor analysis results for the PID5BF+M
domains and total are displayed in Table 2. Table 3 shows the
10 more discriminative PID5BF+M traits (PID5BF+M facets
and total).
The trait domains of disinhibition, negative affectivity, and
antagonism were the best discriminators among patients with
PD and patients with other diagnoses. The antagonism domain
(i.e., ICD-11 dissociality) showed the best predictive capacity
(57.1%). The PID5BF+M total score discriminated better than
the remaining trait domains among PD and non-PD patients.
The trait facets of impulsivity, deceitfulness, emotional
lability, manipulativeness, separation insecurity, intimacy
avoidance, distractibility, eccentricity, and anhedonia were the
best discriminators among patients with PD vs. patients
with other diagnoses. Of these, the manipulativeness
facet showed the best predictive capacity (60.8%). The
PID5BF+M total was the fifth best discriminator among the
two groups.
Table 4 presents the number and percentage of individuals
with a PD diagnosis or other diagnosis scoring above 2 in the
18 PID5BF+M facets and in the seven traits that significantly
differentiated the groups (i.e., negative affectivity, antagonism,
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TABLE 2 | Discriminant factor analysis for the PID5BF+M trait domains and total










1 4 Disinhibition 1.41 1.25 52.5%
2 1 Negative affectivity 1.79 1.65 54.9%
3 3 Antagonisma 0.96 0.83 57.1%
4 7 Total PID5BF+M 1.30 1.21 54.0%
5 5 Psychoticism 1.05 .96 52.1%
6 6 Anankastia 1.48 1.46 50.3%
7 2 Detachment 1.11 1.11 50.1%
aBest predictive capacity.
bTwo-fold cross-validation.
TABLE 3 | Discriminant factor analysis for the PID5BF+M facets and total in the










1 11 Impulsivity 1.69 1.42 49.0%
2 8 Deceitfulness 1.26 1.06 57.5%
3 1 Emotional lability 1.85 1.65 52.5%
4 7 Manipulativenessa 0.75 0.58 60.8%







8 12 Distractibility 1.71 1.60 55.1%
9 14 Eccentricity 1.15 1.03 56.6%
10 5 Anhedonia 1.30 1.18 50.1%
aBest predictive capacity.
bTwofold cross-validation.
disinhibition, emotional lability, manipulativeness, deceitfulness,
and impulsivity).
Elevated scores in three or more of the 18 PID5BF+M facets
differentiate the PD group from the other diagnoses group
(χ2 = 11.124, p = 0.011). Considering the seven facets of the
PID5BF+M that differentiate the group with PD from the other
group, it is sufficient to obtain high results in two or more traits
to be assigned to the PD group (χ2 = 24.098, p= 0.001).
DISCUSSION
The current study sought to investigate the utility of the
PID5BF+M in differentiating patients with PD from other
psychiatric patients. A dimensional approach to identifying
PD based on severity is proposed by several authors (3, 24,
25), and PD severity is the real differentiator between PD
and non-PD in the ICD-11 (9). Although the PID5BF+M
addresses trait qualifiers and not the level of PD severity in itself,
Zimmermann et al. (22) find that the PID5BF+, from which
the PID5BF+M derives, can be used for assessing the severity
of PD. This finding is in line with the ICD-11 conceptualization
that the number, complexity, and pervasiveness of pathological
traits may be an indicator of severity (26) and also with
the notion that the AMPD trait model may be used as a
measure of severity by summing the number of pathological
traits presented (27). Moreover, there is evidence to support
the view that severity represents the global quality (g-factor)
linking all the maladaptive personality features (6, 8, 20, 21).
Therefore, it seems reasonable to predict that maladaptive
traits should be more prominent in those with more severe
personality dysfunction (i.e., PD). Thus, in this study, the
PID5BF+M total score along with the specific domain and facet
scores were expected to differentiate PD patients from other
psychiatric patients.
The internal consistency of the PID5BF+M six domains and
of the total PID5BF+M score in both samples was addressed.
Mean Cronbach’s alphas ranging from 0.70 in the PD sample to
0.72 in the other mental disorders sample were obtained. The
small number of items per domain (each domain is composed of
three facets, each with two items) may have accounted for these
moderate alphas and supported the decision of not calculating
the facets’ alphas. However, the total PID5BF+M score showed
high internal consistency in both samples, 0.86 in the PD sample
and 0.89 in the non-PD sample, thus revealing the reliability of
this score in addressing personality dysfunction.
Regarding the samples’ descriptives and group differences, all
the scales except intimacy avoidance revealed highermeans in the
PD sample. The PD sample showed significantly higher scores
for the total PID5BF+M score, for the trait domains of negative
affectivity, antagonism, and disinhibition, and for the trait
facets of emotional lability, manipulativeness, deceitfulness, and
impulsivity. A small effect size was found for manipulativeness;
however, medium effect sizes were obtained for the other traits in
which significant differences between the groups were found.
Discriminant factor analysis results were in line with the
aforementioned group differences. The best discriminators
among patients with personality disorders vs. patients with
other diagnoses included the domains of disinhibition, negative
affectivity, and antagonism and the facets of impulsivity,
deceitfulness, emotional lability, and manipulativeness. The
PID5BF+M total score was also one of the best discriminators
between the groups (fourth in the domain-level analysis
and fifth in the facet-level analysis) confirming the potential
utility of this indicator for detecting significant levels of
personality dysfunction.
Finally, bearing in mind that the literature on the PID-5
suggests that ratings of 2 (sometimes true) or 3 (very true)
have clinical relevance (23), our results indicate that individuals
with rates above 2 in three or more of the 18 PID5BF+M
facets may have a PD diagnosis. Considering the seven traits
that significantly differentiate the groups (negative affectivity,
antagonism, disinhibition, emotional lability, manipulativeness,
deceitfulness, and impulsivity), two of these traits with rates
above 2 are sufficient to distinguish the PD group from the
non-PD group.
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TABLE 4 | Number and percentage of individuals from the personality disorder (PD) and non-personality disorder (non-PD) samples with scores above 2 in the 18
PID5BF+M facets and in the seven PID5BF+M facets that differentiate the groups.
18 PID5BF+M facets
>2 in 0 >2 in 1 >2 in 2 >2 in 3 Total
traits traits traits or more traits
PD Count 21 19 18 66 124
% within PD 16.9% 15.3% 14.5% 53.2% 100.0%
Other diagnosis Count 87 74 48 123 332
% within PD 26.2% 22.3% 14.5% 37.0% 100.0%
Total Count 108 93 66 189 456
% within PD 23.7% 20.4% 14.5% 41.4% 100.0%
7 PID5BF+M facets
>2 in 0 >2 in 1 >2 in 2 >2 in 3 >2 in 4 >2 in 5 >2 in 6 >2 in 7 Total
traits traits traits or more traits or more traits or more traits or more traits or more traits
PD Count 47 25 26 18 7 1 0 0 124
% within PD 37.9% 20.2% 21.0% 14.5% 5.6% 0.8% 0.0% 0.0% 100.0%
Other diagnosis Count 184 72 51 19 4 2 1 1 334
% within PD 55.1% 21.6% 15.3% 5.7% 1.2% 0.6% 0.3% 0.3% 100.0%
Total Count 231 97 77 37 11 3 1 1 458
% within PD 50.4% 21.2% 16.8% 8.1% 2.4% 0.7% 0.2% 0.2% 100.0%
Bold values highlight the number of traits that distinguish the PD group from the non-PD group and above which a PD diagnosis is suggested.
The prominence of maladaptive traits, particularly the
presence of elevated scores in three or more facets in the
PD group, mirroring the severity of personality dysfunction
(6, 8, 20, 21), appears to support the ability of the PID5BF+M to
differentiate PD from non-PD patients. Moreover, considering
that the PD group was largely composed of borderline PD,
characterized by the presence of facets from the negative
affectivity, antagonism, and disinhibition domains in the AMPD,
the results of the current study suggest that the PID5BF+M also
has the potential to describe the specific traits that characterize
the stylistic manifestations of PD. Therefore, although more
research is needed, the current study appears to support the
validity of the PID5BF+M as a global measure of personality
dysfunction severity beyond just characterizing specific PD
trait expressions.
The absence of other instruments’ data to establish the
convergent validity of the PID5BF+M, the heterogeneity of
the clinical samples’ composition and the small number of
participants are limitations of this study. In particular, the fact
that the PD sample has other diagnoses in comorbidity may
overshadow the differences found. However, the study supports
usage of the PID5BF+Mfor PD assessment, stressing its potential
to identify patients with more severe personality dysfunction,
that is, those who have higher scores in most of the maladaptive
traits, and also highlighting the specific stylistic manifestations
of the personality dysfunction. Moreover, considering that the
PID5BF+M traits encompass traits described in both the ICD-11
PD classification system and the DSM-5 AMPD, it is plausible to
expect that the current study, along with previous studies (14, 22),
may contribute to future developments of the DSM-5, namely by
bringing it closer to the ICD-11, the WHO authoritative mental
disorders classification system. Finally, for clinical practice and
the diagnostic process, it would be incommensurably fruitful
to have a diagnostic tool with fewer items, which is less time
consuming and bridges the ICD-11 and the DSM-5 personality
disorders classification systems.
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